Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (4410)	7/17/1998 12:26:00 AM
From: Tunica Albuginea	Read Replies (3) \| Respond to of 9523

BigKNY3, your comparison of Viagra to Prozac is absurd. The deaths from Prozac were all due to patients who had the illness termed "Endogenous Depression ". The suicide rate in this illness is high and well known. Also it takes 6 weeks of taking Prozac ( in adequate doses ) to prevent this suicidal ideation and suicides. Unfortunately some physicians are not aware of this, they prescribed Prozac and sent a suicidal patient home not realizing that Prozac would take 6 weeks to work. Some of these patients went home and committed suicide shortly thereafter. ( some didn't even take the pill as prescribed ). The Church of Scientology tried to make a buck on this and they helped people sue ( I believe ), although many families sued on their own. However expert medical opinion was unanimous and overwhelming in demonstrating that ALL antidepressants ( not just Prozac ) take 6 weeks to work and that suicides are frequent in this period. In fact suicides are a hallmark of Endogenous Depression. Case closed. Viagra is a different ballgame. We have PFE which run a skewed study by by not reflecting in it's Phase III trial the true frequency of coronary artery disease ( CAD ), by admitting only 20 patients taking Nitro in their 4000 patient study, when in fact 75% OF ALL MEN with organic impotence DIE OF CAD/HEART ATTACKS So now we have 31 deaths so far which is only the tip of the iceberg. Your comparison of Viagra to Prozac is only a reflection of the profound ignorance that exists world wide of CAD, the No 1 killer in America. And PFE has just invented a drug that will turn what used to be a fun act ( sex ) , into an unsupervised, open-ended - treadmill stress-test, in high risk people ( diabetics, arteriosclerotics, etc. ), resulting in a heart attack; It then proceeded to transform the No 1 immediate therapy for these heart attack victims , Nitroglycerin , into an instant killer . TA

To: BigKNY3 who wrote (4410)	7/17/1998 12:37:00 AM
From: zurdo	Respond to of 9523

Anthony, BigKNY3 and Thread: This appears to be a classic opportunist's frivolous lawsuit...I am not an attorney, but even a layman can see the huge flaws in this lawsuit....There are always plenty of shysters ready and willing to team up with a fellow like this whenever there are deep pockets to plunder...if they can..I am long for a considerable investment in PFE, and I will lose no sleep over this pathetic attempt at extortion...

To: BigKNY3 who wrote (4410)	7/17/1998 11:06:00 AM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

Transcript of yesterday's Larry King Live, which focused quite a bit about Viagra during the first part of the program. Not terribly positive. Alternative Versus Traditional Medicine: What's Best For You? cnn.com

To: BigKNY3 who wrote (4410)	7/18/1998 11:39:00 AM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

Big Pharma Report: 7/18/98 Have PFun! BigKNY3 _______________________________________________ -Big Pharma stayed ahead of the record breaking general market with a 4.0% increase this week as compared to the Dow gain of 2.5% and NASDAQ jump of 3.4%. -As the great search for Pharma values continues, week ending 7/10/98's #13 (AHP) and #12 (JNJ) were last week's leaders; AHP up 9.7% followed by JNJ (+7.9%). -After pacing Big Pharma with a 9.6% during the week ending July 10th, PFE (-1.8%) was flat in a roller coaster action. Accordingly, PFE went from #1 to #13 in the weekly rankings. -In July, PFE is up 6.5%.... ranking 7th in Big Pharma. - On Friday, Big Pharma closed at its all-time high increasing YTD 35.7%. -In the YTD race, the "Big 3" held their positions with #1 WLA (+92.2%) followed by SGP (+66.5%) and PFE (+55.2). These "Big 3" have increased 67.8% as compared to the "Healthy Other 10" (+26.1%). That's right, WLA is at the 90 level. PFE News You Can Use The New York Post examines the Viagra lawsuit nypostonline.com Transcript from last Thursday's Larry King Live show "Alternative Versus Traditional Medicine: What's Best for you". cnn.com Particularly note that Dr. Ruth Westheimer thinks there is need for education with Viagra (she mentions it 7 times). Dr. Deepak Chopra also misquotes the New England Journal of Medicine sildenafil study; "What the public is not aware that 50% responded to placebo. So why don't we hear about that?" The correct placebo response in this study was 22%. Dr. Tim Johnson of ABC-TV did attempt to correct Dr. Chopra. nejm.org -PFE announced on Friday that they will invest $280 million to expand the Viagra manufacturing plant in Ireland. -Prompted by Viagra, California's health plan regulators will hold hearings in August to help set policies on what drugs should be covered by HMO's. -Viagra stimulates many discussions from the Sacramento Bee (6/29/98) sacbee.com Mutual Fund PFriend Highlights of an interview with a fund manager who has major PFE holdings (Source: Investor's Business Daily) Fund: American Express IDS Fund Manager: Keith Tufte: Date: 7/17/98 PFE Holdings (3/98): 8,276,000 Current Value (7/17/98): $957,947,000 PFE position in fund: #2 PFE Comments: "The fund family has been buying PFE again..We feel good about PFE. Their Viagra sales were stronger in the second quarter than expected. They are going to roll out the drug in the second half into Europe and next year into Japan....PFE is selling WLA's Lipitor. Co- marketing plans also are in the works with MTC for its anti-inflammatory drug Celebra. It has become the "co-marketer of choice".